Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Alter (Marburg, Germany), T. Lucke (Munich, Germany), H. Watz (Grosshansdorf, Germany), S. Andreas (Göttingen, Germany), K. Kahnert (Munich, Germany), F. Trudzinski (Heidelberg, Germany), T. Speicher (Marburg, Germany), S. Söhler (Marburg, Germany), R. Bals (Homburg, Germany), T. Welte (Hannover, Germany), K. Rabe (Grosshansdorf, Germany), J. Vestbo (Manchester, United Kingdom), E. Wouters (Maastricht, Netherlands), C. Vogelmeier (Marburg, Germany), R. Jörres (Munich, Germany). Late Breaking Abstract - Chronic coronary artery disease and decline of lung function as predictors of mortality and exacerbation risk in stable COPD: Results from COSYCONET. 1060

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Indacaterol/glycopyrronium versus salmeterol/fluticasone in chronic obstructive pulmonary disease: a meta-analysis on the protection against the risk of exacerbation Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene Source: Eur Respir J, 55 (2) 1901812; 10.1183/13993003.01812-2019 Year: 2020 Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Acute myocardial infarction among Spanish adults with and without COPD: Cumulative incidence and outcomes Source: International Congress 2014 – COPD markers Year: 2014 Angiographically objectified presence of coronary artery disease in patients with exacerbated chronic obstructive pulmonary disease and raised troponin I - The BEETHOVEN trial Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Visual estimate of coronary artery calcium predicts cardiovascular disease in COPD Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Left heart dysfunction in acute exacerbation of COPD: Only risk factor or even outcome? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Predictors of coronary heart disease in patients with COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications Source: International Congress 2015 – COPD: notable points Year: 2015 Impact of peripheral artery disease on functional capacity in patients with COPD: Results of the COSYCONET study Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods Year: 2015 Comparison of cardiopulmonary exercise test in COPD patients with and without coronary artery disease Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity Year: 2013 Asthma and COPD in patients with coronary artery disease - The unmet demands Source: International Congress 2016 – Best abstracts in asthma and COPD Year: 2016 The CANT score: Predicting mortality in exacerbations of chronic obstructive pulmonary disease Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 COPD mortality - Is it all COPD? Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Assessment of cardiovascular comorbidity Source: Eur Respir Mon 2013; 59: 28-49 Year: 2013 Comorbit coronary artery disease is related to worse outcomes in patients hospitalised for COPD exacerbation Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Late Breaking Abstract - Co-morbid disease clusters in chronic obstructive pulmonary disease: the ERICA study Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016